Journal article
What are the obligations of pharmaceutical companies in a global health emergency?
EJ Emanuel, A Buchanan, SY Chan, C Fabre, D Halliday, J Heath, L Herzog, RJ Leland, MS McCoy, OF Norheim, C Saenz, GO Schaefer, KC Tan, CH Wellman, J Wolff, G Persad
Lancet | Published : 2021
Grants
Funding Acknowledgements
We thank Amaya Diana, Aaron Glickman, and Patricia Hong for their assistance with research, critical review of the manuscript, and other details. We also thank Florencia Luna for useful conversations. The Colton Family Foundation partly supported the research for this project. The views expressed here, and any errors, are solely those of the authors and should not be attributed to any of their employers. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.